filmov
tv
ALEX Trial: Frontline Therapy for ALK-Rearranged NSCLC
Показать описание
Panelists Suresh S. Ramalingam, MD; Giorgio Scagliotti, MD, PhD; and Marina Garassino, MD, review the data from the ALEX trial and its impact on frontline treatment for ALK/ROS1-translocated metastatic non–small cell lung cancer.
0:08:15
0:01:37
0:06:51
0:02:23
0:11:02
0:03:04
0:00:55
0:01:17
0:05:03
0:01:42
0:01:35
0:00:41
0:23:48
0:07:42
0:01:56
0:04:14
0:03:21
0:07:49
0:01:37
0:01:00
0:00:29
0:00:06
0:00:22
0:04:00